Obstructive Pulmonary Pharmacology (Exam 1b) Flashcards
Class of medications that dilate the bronchioles
-Beta2-adrenergics
-Inhaled Anticholinergics
-Xanthine derivatives
Class of medications that decrease bronchial inflammation
-Glucocorticoids
-Mast cell stabilizer
-LTRA’s
Bronchodilators
Used to treat all respiratory disease
Work by relaxing bronchial smooth muscle (causing dilation)
Beta-Adrenergic Agonists (Bronchodilator)
-Can be long or short acting
-Usually end in -erol (both short and long)
-Crucial to know if it short or long acting
Short Acting Beta Adrenergic Agonists
-Albuterol (PO/Inhalant)
-Levalbuterol Inhalant
Long Acting Beta-Adrenergic Agonists
-Salmeterol
-Formoterol
All long acting are in form of inhalant
Short Active vs Long acting inhalation
-Most B2 agonist are short acting (SABA)
-SABA are Rescue drugs
-Duration = 4-6 H
-Long acting B2 agonist are preventer drugs
-Duration = 12-24 H
Beta-adrenergic Agonist: MOA
Mimic action of SNS –> Flight or fight
Relax and dilate the ariways by stimulating the Beta 2 adrenergic receptors throughout the lungs
Causing bronchial dilation and increased airflow into and out of the lungs = goal
Beta-adrenergic agonist: Indications
Prevention or relief of bronchospasm related to asthma/bronchitis/other pulmonary conditions
Beta-adrenergic agonist: NSG considerations
Can be given with beta blocker, but may diminish effects (give more)
Avoid use with MAOI and sympathomimetics (ephedrine/sudafed) increase risk of HTN
Diabetics may need higher doses of meds because raises blood sugar
Beta-adrenergic agonist: contraindications
Uncontrolled HTN, cardiac dysrhythmias, high risk of stroke
Beta-adrenergic agonist: Adverse effects
hyper or hypo tension
bronchospasm
insomnia
restlessness
anorexia
cardiac stimulation
HA
Inhalers are given
minimize systemic side effects
Don’t see cardiac and htn problems as much because we are just aim at the beta 2 receptors in the lungs
Inhaler PDF on canvas
Selective Beta Agonist: Albuterol
-Short-acting beta2 agonist (SABA): onset is mins
-Inhalation Q4-6H
-Rescue drug
-Delivery method: MDI or nebulizer —> FIRST line of treatment for acute asthma attack
Albuterol: Rescue Drug
Use of more than on canister per month indicates inadequate control of asthma and need for initiating or intensifying anti-inflammatory therapy
(200 actuations per canister)
Also used for prevention of EIA (Exercise induced asthma)
Albuterol: Indications
Treatment of COPD umbrella
Acute episodes of wheezing, chest tightness, and SOA
Salmeterol: class
LAB2A
Salmeterol: Indications
Not for acute treatments –> it is a maintenance drug
Worsening of COPD
Moderate - Severe asthma
Always given with an inhaled corticosteroid, no indicated for monotherapy
Key Point: Salmeterol
Always given with an inhaled corticosteroid, not indicated for monotherapy
Salmeterol: Warning
Has been associated with increased asthma-related deaths (more common in black AA’s)
Anticholinergics
Still type of bronchodilators —> instead of working on beta receptors this works on acetylcholine receptors
Giving Anti-Cholinergic agents results in
-Turning off cholinergic response (PNS) and turning on SNS
-SNS dominates = Bronchodilation (Thus increasing perfusion to heart, lungs, and brain)
Anticholinergic: KEY point
-By blocking the effects of acetylcholine (anticholinergic drugs), we INHIBIT the normal physiological response
-Less Bronchoconstriction and less mucus production